[Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: result of the COVID-19-GEAS patient survey].

Fanlo, P; Espinosa, G; Adán, A; Arnáez, R; Fonollosa, A; Heras, H; Oteiza, J; Del Carmelo Gracia Tello, B; Comet, L Sáez; Pallarés, L; Fanlo, Patricia; Espinosa, Gerard; Adán, Alfredo; Arnáez, Rubén; Fonollosa, Alejando; Heras, Henar; Oteiza, Julio; Tello, Borja del Carmelo Gracia; Comet, Luis Sáez; Pallarés, Lucio

Introduction The objetive of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Material and methods Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. Results A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and caucasian (82%), with a mean age of 48 years. The most frequent SAEs were Behçet's disease followed by sarcoidosis and systemic lupus erythematosus. 46% of the patients were receiving corticosteroid treatment at a mean prednisone dose of 11 mg/day. Regarding infection, 14 (50%) patients reported symptoms compatible with SARS-CoV-2 infection. RT-PCR was performed on the nasopharyngeal smear in two patients and in one of them (4%) it was positive. Conclusions Both asymptomatic and symptomatic COVID-19 patients with ASD-associated UNI had received similar immunosuppressive treatment.